These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 3559452)

  • 21. Vascular effects of arginine vasopressin during fluid deprivation in the rat.
    Aisenbrey GA; Handelman WA; Arnold P; Manning M; Schrier RW
    J Clin Invest; 1981 Apr; 67(4):961-8. PubMed ID: 7204578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of renomedullary interstitial cells in Brattleboro rats after vasopressin treatment.
    Sundelin B; Bohman SO
    Lab Invest; 1988 Apr; 58(4):388-94. PubMed ID: 3357333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The antidiuretic action of 1-deamino-8-D-arginine vasopressin (DDAVP) in man.
    Radó JP; Marosi J; Szende L; Borbély L; Takó J; Fischer J
    Int J Clin Pharmacol Biopharm; 1976 Apr; 13(3):199-209. PubMed ID: 950263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Individual differences in the antidiuretic response induced by single doses of 1-deamino-8-D-arginine-vasopressin (DDAVP) in patients with pituitary diabetes insipidus.
    Radó JP; Marosi J; Borbély L; Takó J
    Int J Clin Pharmacol Biopharm; 1976 Dec; 14(4):259-65. PubMed ID: 1002361
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the pharmacologic properties of a vasopressin antagonist in Brattleboro rats.
    Mah SC; Hofbauer KG
    J Pharmacol Exp Ther; 1988 Jun; 245(3):1028-32. PubMed ID: 2968448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and some pharmacological properties of deamino(4-threonine,8-D-arginine)vasopressin and deamino(8-D-arginine)vasopressin, highly potent and specific antidiuretic peptides, and (8-D-arginine)vasopressin and deamino-arginine-vasopressin.
    Manning M; Balaspiri L; Moehring J; Haldar J; Sawyer WH
    J Med Chem; 1976 Jun; 19(6):842-5. PubMed ID: 950656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An exploration of the effects of L- and D-tetrahydroisoquinoline-3-carboxylic acid substitutions at positions 2, 3 and 7 in cyclic and linear antagonists of vasopressin and oxytocin and at position 3 in arginine vasopressin.
    Manning M; Cheng LL; Stoev S; Bankowski K; Przybyiski J; Klis WA; Sawyer WH; Wo NC; Chan WY
    J Pept Sci; 1995; 1(1):66-79. PubMed ID: 9222985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative study of the antidiuretic effects of Adiuretin-SD (DDAVP) and Pitressin Tannate in diabetes insipidus.
    Czakó L; Julesz J; László FA
    Int J Clin Pharmacol Biopharm; 1978 Jan; 16(1):10-3. PubMed ID: 631964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Water balance in the Brattleboro rat: considerations for hormone replacement therapy.
    Kinter LB
    Ann N Y Acad Sci; 1982; 394():448-63. PubMed ID: 6960776
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of diabetes insipidus with 1-deamino-8-d-arginine vasopressin.
    Czakó L; Mezei G; László FA
    Acta Med Acad Sci Hung; 1975; 32(1):75-84. PubMed ID: 1233863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and some pharmacological properties of 18 potent O-alkyltyrosine-substituted antagonists of the vasopressor responses to arginine-vasopressin.
    Manning M; Lammek B; Bankowski K; Seto J; Sawyer WH
    J Med Chem; 1985 Oct; 28(10):1485-91. PubMed ID: 4045923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abnormalities in thyrotropin and thyroxine secretion in Brattleboro rats.
    Fujimoto S; Hedge GA
    Ann N Y Acad Sci; 1982; 394():549-59. PubMed ID: 6817680
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of arginine vasopressin antagonist on renal water excretion in glucocorticoid and mineralocorticoid deficient rats.
    Ishikawa S; Schrier RW
    Kidney Int; 1982 Dec; 22(6):587-93. PubMed ID: 7162034
    [No Abstract]   [Full Text] [Related]  

  • 34. Design of potent antagonists of the vasopressor response to arginine-vasopressin.
    Bankowski K; Manning M; Haldar J; Sawyer WH
    J Med Chem; 1978 Sep; 21(9):850-3. PubMed ID: 722751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Augmentation by chlorpropamide of 1-deamino-8-D-arginine vasopressin-induced antidiuresis and stimulation of renal medullary adenylate cyclase and accumulation of adenosine 3',5'-monophosphate.
    Moses AM; Coulson R
    Endocrinology; 1980 Mar; 106(3):967-72. PubMed ID: 6243558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antidiuretic responses to injected desmopressin, alone and with indomethacin.
    Moses AM; Moses LK; Notman DD; Springer J
    J Clin Endocrinol Metab; 1981 May; 52(5):910-3. PubMed ID: 7228994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic blockade of vasopressin receptors in rats.
    Hofbauer KG; Mah SC; Opperman JR
    J Cardiovasc Pharmacol; 1986; 8 Suppl 7():S56-60. PubMed ID: 2434774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design of more potent and selective antagonists of the antidiuretic responses to arginine-vasopressin devoid of antidiuretic agonism.
    Manning M; Klis WA; Olma A; Seto J; Sawyer WH
    J Med Chem; 1982 Apr; 25(4):414-9. PubMed ID: 7069720
    [No Abstract]   [Full Text] [Related]  

  • 39. The abnormal quinine drinking aversion in the Brattleboro rat with diabetes insipidus is reversed by the vasopressin agonist DDAVP: a possible role for vasopressin in the motivation to drink.
    Laycock JF; Chatterji U; Seckl JR; Gartside IB
    Physiol Behav; 1994 Mar; 55(3):407-12. PubMed ID: 8190753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antidiuretic and urinary cyclic AMP response of vasopressin in normal rats and in rats with lithium-polyuria.
    Christensen S; Geisler A
    Acta Pharmacol Toxicol (Copenh); 1977 Mar; 40(3):447-54. PubMed ID: 190861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.